Trazodone Use in Elderly Patients

Introduction to Trazodone Use

The American Academy of Family Physicians recommends that trazodone should be used with extreme caution in elderly patients, starting at 25 mg daily with careful titration, and is best reserved for specific situations such as agitation in dementia or insomnia when other options have failed, while recognizing it carries significant risks including orthostatic hypotension, falls, and fractures that may equal or exceed those of alternative agents 1, 2

The American Academy of Family Physicians suggests an initial dose of 25 mg per day, typically at bedtime, with a maximum dose of 200-400 mg per day in divided doses 1, 2
Titration should be gradual, increasing by increments of the initial dose every 5-7 days as tolerated, according to the American Academy of Family Physicians 3

The American Academy of Sleep Medicine recommends against using trazodone for chronic insomnia, citing low-quality evidence that benefits do not outweigh harms, with a strength of evidence considered low 4
The VA/DoD guideline also advises against trazodone for chronic insomnia, noting no differences in sleep efficiency versus placebo and an adverse effect profile that outweighs limited benefits, based on moderate-quality evidence 5, 6
The American Academy of Family Physicians suggests that trazodone may be useful for mood stabilization and antiagitation in Alzheimer's disease, as an alternative to antipsychotics for control of severe agitated, repetitive, and combative behaviors 1, 2

Trazodone may be preferred over tricyclic antidepressants due to its lower anticholinergic effects, according to the American Academy of Family Physicians and the American Academy of Sleep Medicine 3, 8

The American Academy of Family Physicians recommends starting trazodone at 25 mg at bedtime, with gradual titration by 25 mg increments every 5-7 days as tolerated 1, 2, 3
For chronic insomnia alone, the American Academy of Sleep Medicine and the VA/DoD guideline recommend considering other options first, given the current guidelines against trazodone 4, 5, 6
For agitation/BPSD in dementia, trazodone is a reasonable alternative to antipsychotics, recognizing similar fall/fracture risk but lower mortality, according to the American Academy of Family Physicians 1, 2
For depression with insomnia/anxiety, trazodone may be appropriate, particularly if other antidepressants have failed, based on recommendations from the American Academy of Family Physicians and the American Academy of Sleep Medicine 3, 8